NELFCD and systemic lupus erythematosus: Along with Th-1-driven autoimmune diseases, it is tempting to investigate the impact of CD137-CD137L system manipulation on autoimmune conditions chiefly driven by the Th17 axis such as EAE and systemic lupus erythematosus (SLE).